Beyond Air
Garden City, United States · Biotechnology, Healthcare, Health Care
Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neona
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Garden City, United States
- Employees
- 54
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (XAIR)
- Website
- www.beyondair.net
- Company page
Recent activity at Beyond Air
- : SEC 8-K (7.01):
- : SEC 8-K (7.01): This filing reports a Regulation FD Disclosure by Beyond Air, Inc. dated October 8, 2026. The information includes a press release that the company believes is relevant for shareholders, although the company makes no admission regarding the materiality of the information shared. The report refers to Exhibit 99.1, which likely contains significant updates or announcements intended to inform investors while ensuring compliance with Regulation FD standards regarding material disclosures. No financial amounts or specific terms are mentioned in this filing.
- : SEC 8-K (5.02): On September 23, 2026, Beyond Air, Inc. (the 'Company') entered into an Employment Agreement with Robert Goodman, who has been serving as Chief Executive Officer since March 27, 2026. The agreement, effective immediately, stipulates that Mr. Goodman will receive an annual base salary of no less than $650,000, with potential annual bonuses that could range from 0% to 150% of his base salary based on performance. The agreement does not have a fixed term and provides specific terms for termination, including severance provisions in the event of a termination without cause or resignation for good reason. This appointment and agreement demonstrate the Company's commitment to its leadership and strategic direction.
About Beyond Air: questions and answers
What does Beyond Air do?
Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neona
Where is Beyond Air headquartered?
Beyond Air is headquartered in Garden City, United States.
How many employees does Beyond Air have?
Beyond Air has about 54 employees.
What is the latest news on Beyond Air?
On Nov 13, 2026, SEC 8-K (7.01):
Is Beyond Air a public company?
Yes. Beyond Air is publicly traded under the ticker XAIR.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy